TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected

Axel Hauschild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.